|
|
|
Volumn 46, Issue 8 II, 1985, Pages 30-33
|
|
Review of clinical and laboratory experiences with molindone hydrochloride
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APOMORPHINE;
CHLORDIAZEPOXIDE;
CHLORPROMAZINE;
CLOZAPINE;
DOMPERIDONE;
DOPAMINE RECEPTOR;
HALOPERIDOL;
MOLINDONE;
NEUROLEPTIC AGENT;
PLACEBO;
SPIPERONE;
THIORIDAZINE;
TIOTIXENE;
TRANYLCYPROMINE;
TRIFLUOPERAZINE;
ADVERSE DRUG REACTION;
AKATHISIA;
CENTRAL NERVOUS SYSTEM;
DRUG HALF LIFE;
DRUG RECEPTOR BINDING;
EXTRAPYRAMIDAL SYMPTOM;
HUMAN;
INTOXICATION;
NERVOUS SYSTEM;
NEUROTOXICITY;
PHARMACODYNAMICS;
PHARMACOKINETICS;
PHARMACOLOGY;
PRIORITY JOURNAL;
SHORT SURVEY;
SURVEY;
THERAPY;
AKATHISIA, DRUG-INDUCED;
BASAL GANGLIA DISEASES;
CLINICAL TRIALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DYSKINESIA, DRUG-INDUCED;
HALF-LIFE;
HALOPERIDOL;
HUMAN;
INDOLES;
MENTAL DISORDERS;
MOLINDONE;
PSYCHIATRIC STATUS RATING SCALES;
RECEPTORS, DOPAMINE;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
|
|
EID: 0022230055
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|